SCHEMBL7571208

SCHEMBL7571208

O=C1N=C(O)C(c2ccc(Br)cc2)=NC1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MAPT P10636 1/20 0.44
CES2 O00748 2/20 0.43
HDAC3 O15379 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
BDKRB2 P30411 5/20 0.38
MMP2 P08253 3/20 0.36
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP3A4 P08684 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GAA P10253 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7572646 0.91 BDKRB2 (0.41) CES2HDAC3HDAC6HDAC1HDAC8
SCHEMBL7572458 0.90 BDKRB2 (0.42) CES2HDAC3HDAC6HDAC1HDAC8
SCHEMBL7571381 0.89 HDAC3 (0.42) HDAC3HDAC6HDAC1HDAC8BDKRB2
SCHEMBL7571711 0.87 CES2 (0.38) CES2HDAC3HDAC6HDAC1HDAC8
SCHEMBL7576544 0.87 CES2 (0.44) MAPTCES2HDAC3HDAC6HDAC1
SCHEMBL7572631 0.82 CES2 (0.42) SMN1; SMN2CES2HDAC3HDAC6HDAC1
SCHEMBL7572718 0.82 CES2 (0.43) MAPTCES2HDAC3HDAC6HDAC1
SCHEMBL7570886 0.81 PSD (0.37) NPC1POLBRAB9AHDAC3HDAC6
SCHEMBL7569645 0.81 DHODH (0.38) NPC1RAB9AMAPTCES2HDAC3
SCHEMBL7570328 0.79 CES2 (0.45) CES2HDAC3HDAC6NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002085369-A1 INHIBITORS OF ANTHRAX LETHAL FACTOR ACTIVITY STRUCTURAL BIOINFORMATICS, INC. (US) 2002-10-31 WO disclosed